Absorbable Nasal Implant Devices Market - By Product Type (Drug Eluting Absorbable Nasal Implants, Non-Drug Eluting Nasal Implants), By Material Type (Polymer, CMC), By End-use (Hospitals, Ambulatory Surgical Centers) & Forecast 2023 - 2032

Absorbable Nasal Implant Devices Market - By Product Type (Drug Eluting Absorbable Nasal Implants, Non-Drug Eluting Nasal Implants), By Material Type (Polymer, CMC), By End-use (Hospitals, Ambulatory Surgical Centers) & Forecast 2023 - 2032


Global Absorbable Nasal Implant Devices Market size will expand significantly through 2032 High prevalence of nasal disorders in aging people has increased the demand for absorbable nasal implant devices. Moreover, increasing healthcare expenditure across the globe has fostered the development of novel absorbable nasal implant devices, supplementing industry growth. In fact, the industry leaders operating in the space are focusing on product innovations to outshine the competition. Increasing strategic efforts will bring commendable gains to the absorbable nasal implant devices industry over 2023-2032.

The overall market share is classified based on product, material, end-use, and region.

With respect to product, the non-eluting segment will grow at a significant CAGR through 2032. Reduced inflammation with these devices favors their adoption. These implants are typically made from biocompatible materials that are absorbed by the body over time. As the implant absorbs, it reduces the risk of inflammation or foreign body reactions. This can benefit patients prone to excessive scar tissue formation or those with a history of adverse reactions to foreign materials.

Based on material, the market value from the carboxy methyl cellulose (CMC) segment will depict considerable growth through 2032. The versatility and ease of use of these implants support their adoption. These can be used in various nasal procedures, including septoplasty, rhinoplasty, and nasal trauma reconstruction. They can be molded and shaped to fit the specific anatomical requirements of each patient, making them versatile for different surgical applications.

Based on end-use, absorbable nasal implant devices market from the ambulatory surgical centers (ASCs) segment will surge significantly through 2032. ASCs often provide a more personalized and patient-centered experience. The smaller size of these facilities allows for more individualized care and attention. Patients may have more direct access to their surgical team, resulting in higher level of patient satisfaction and comfort. Moreover, the growing number of ambulatory surgical centers is creating lucrative opportunities for segment growth.

From the regional perspective, the Asia Pacific absorbable nasal implant devices market share will grow at a notable CAGR between 2023 and 2032. Growing prevalence of nasal disorders, coupled with the flourishing medical device sector, is generating a plethora of opportunities for regional growth. As per India’s IBEF, in FY22, the export of medical devices from the country was worth USD 2.90 billion and is projected to reach USD 10 billion by 2025.


Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Absorbable nasal implant devices industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Material type trends
2.6 End-use trends
Chapter 3 Absorbable Nasal Implant Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of nasal congestion
3.2.1.2 Rising number of nasal reconstruction surgeries, such as rhinoplasty and septoplasty
3.2.1.3 Technological advancements
3.2.1.4 Rising demand & surged awareness
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of product awareness
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By material type
3.3.3 By end use
3.4 COVID- 19 impact analysis
3.5 Pricing analysis, 2022, by region
3.5.1 North America
3.5.1.1 U.S.
3.5.1.2 Canada
3.5.2 Europe
3.5.2.1 Germany
3.5.2.2 UK
3.5.2.3 France
3.5.2.4 Spain
3.5.2.5 Italy
3.5.2.6 Poland
3.5.2.7 Switzerland
3.5.2.8 The Netherlands
3.5.3 Asia Pacific
3.5.3.1 China
3.5.3.2 Japan
3.5.3.3 India
3.5.3.4 Australia
3.5.3.5 South Korea
3.5.3.6 Indonesia
3.5.3.7 Philippines
3.5.3.8 Vietnam
3.5.4 Latin America
3.5.4.1 Brazil
3.5.4.2 Mexico
3.5.4.3 Argentina
3.5.4.4 Colombia
3.5.4.5 Chile
3.5.4.6 Peru
3.5.5 MEA
3.5.5.1 South Africa
3.5.5.2 Saudi Arabia
3.5.5.3 UAE
3.5.5.4 Israel
3.5.5.5 Egypt
3.5.5.6 Turkey
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Reimbursement scenario
3.8 Product launch/approval scenario
3.9 Material type insights
3.10 Key market trends
3.11 Technological advancements
3.12 Gap Analysis
3.13 Porter's analysis
3.14 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Size and Forecast, By Product Type (USD Million & Units)
5.1 Key trends, by product type
5.2 Drug Eluting Absorbable Nasal Implant Devices
5.2.1 Corticosteroids Eluting Implants
5.2.2 Antibiotics Eluting Implants
5.2.3 Others
5.3 Non-Drug Eluting Nasal Implants Devices
Chapter 6 Size and Forecast, By Material Type (USD Million)
6.1 Key trends, by material type
6.2 Polymer
6.3 Carboxy Methyl Cellulose (CMC)
6.4 Others
Chapter 7 Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Ambulatory Surgical Centers
7.4 Others
Chapter 8 Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 Smith and Nephew plc
9.2 Intersect ENT, Inc.
9.3 Spirox, Inc. (Entellus Medical)
9.4 Stryker Corporation
9.5 Johnson & Johnson, Inc.
9.6 SinuSys Corporation
9.7 Surgiform Technology Ltd

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings